Cancer Treatment Centers of America® at Midwestern Regional Medical Center Recognized for Exemplary Stem Cell Treatment and Cell Therapy Program

ZION, Ill., Sept. 30, 2014 /PRNewswire-USNewswire/ -- Cancer Treatment Centers of America (CTCA^®) at Midwestern Regional Medical Center (Midwestern) has been recognized by the Foundation for the Accreditation of Cellular Therapy (FACT) at the University of Nebraska Medical Center for demonstrating compliance with the FACT-JACIE International Standards for Cellular Therapy Product Collection, Processing and Administration.

FACT, an internationally-recognized accrediting body for hospitals and medical institutions offering stem cell transplant, awarded CTCA at Midwestern with the prestigious accreditation for meeting rigorous standards in a variety of stem cell therapies, including clinical care, donor management, cell collection, processing, storage, transportation, administration and cell release. As a member of the National Marrow Donor Program (NMDP®), CTCA at Midwestern offers a Stem Cell Transplant and Cell Therapy program that provides a full spectrum of transplantation services and advanced treatment options for hematologic cancers.

"It is with great pride that CTCA at Midwestern receives the esteemed FACT accreditation," said Scott Jones president and CEO of CTCA at Midwestern. "This is a tremendous milestone for our Stem Cell Treatment and Cell Therapy Program and evidence of the quality of care our exceptional team provides to our patients on a daily basis."

FACT accreditation is attained through evaluation of detailed clinical documentation and an on-site inspection to determine if an organization is in compliance with current FACT standards and the United States Food and Drug Administration's rules for Good Tissue Practice. FACT Standards are defined by leading experts based on the latest knowledge of the field of cellular therapy. Since 2007, FACT accreditation has been used in determining the U.S. News & World Report rankings of transplant centers for the "America's Best Hospitals" and "America's Best Children's Hospitals" lists.

"Our Stem Cell Treatment and Cell Therapy Program provides world-class care to each patient throughout the duration of their stay at the hospital and beyond," said Istvan Redei, MD, national director of stem cell transplant and cell therapy and hematologist-oncologist at CTCA at Midwestern. "Receiving FACT accreditation is a great honor and will demonstrate to patients that they are in good hands."

To learn more about FACT accreditation or view a full list of accredited organizations, visit www.factwebsite.org. For more information on CTCA at Midwestern, visit www.cancercenter.com.

About Cancer Treatment Centers of America®
Cancer Treatment Centers of America, Inc. (CTCA) is a national network of five hospitals that specialize in the treatment of patients fighting complex or advanced-stage cancer.  CTCA offers an integrative approach to cancer treatment that combines surgery, radiation, and chemotherapy with nutritional counseling, naturopathic medicine, mind-body therapy, and spiritual support to enhance quality of life and minimize side effects during treatment.  The company serves patients from all 50 states at hospitals located in Atlanta, Chicago, Philadelphia, Phoenix and Tulsa.  Known for delivering the Mother Standard^® of care and Patient Empowerment Medicine^®, CTCA provides patients with comprehensive information about their treatment options so they can participate in their treatment decisions.  For more information about CTCA, go to www.cancercenter.com.

About Cancer Treatment Centers of America at Midwestern Regional Medical Center
Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center is a 73 bed specialty hospital dedicated to treating patients battling complex cancer.  CTCA® at Midwestern is nationally recognized for providing innovative and individualized cancer care and has been designated by the American Nurses Credentialing Center (ANCC) a Magnet Recognized® program, ranking the hospital as one of the top seven percent in the nation for nursing excellence.  CTCA at Midwestern has been designated by the National Quality Measures for Breast Centers Program (NQMBC^®) as a Certified Quality Breast Center of Excellence™, ranking the hospital among the top centers in the country for quality breast cancer care.  CTCA at Midwestern is the only Certified Breast Center of Excellence in Illinois, and one of only 41 nationally.  As a member of the National Marrow Donor Program (NMDP) the hospital also offers a Stem Cell Transplant and Cell Therapy program that provides a full spectrum of transplantation services and advanced treatment options for hematologic cancers. CTCA is recognized by the Foundation for the Accreditation of Cellular Therapy (FACT) at the University of Nebraska Medical Center for demonstrating compliance with the FACT-JACIE International Standards for Cellular Therapy Product Collection, Processing and Administration. CTCA at Midwestern is also recognized by the Quality Oncology Practice Initiative (QOPI®) Certification Program, an affiliate of the American Society of Clinical Oncology (ASCO), for meeting the highest standards for quality cancer care. CTCA at Midwestern is proud to use the latest technology to offer advanced treatment for cancer and is currently one of only a few hospitals in the nation to combine recent advances in brain mapping and navigation to perform minimally invasive brain surgery on hard to reach brain tumors.

Logo - http://photos.prnewswire.com/prnh/20090612/CTCALOGO
Logo - http://photos.prnewswire.com/prnh/20140930/149373

SOURCE Cancer Treatment Centers of America

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED